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Background.This study evaluatedwhether largevenous-arterialCO2 gap(PCO2 gap) preoperatively isassociatedtopoor outcome.
Method. Prospective study which included adult high-risk surgical patients. The patients were pooled into two groups: wide [P(v-
a)CO2] versus narrow [P(v-a)CO2]. In order to determine the best value to discriminate hospital mortality, it was applied a ROC
(receiver operating characteristic) curve for the [P(v-a)CO2] values collected preoperatively, and the most accurate value was
chosen as cut-oﬀ to deﬁne the groups. Results. The study included 66 patients. The [P(v-a)CO2] value preoperatively that best
discriminated hospital mortality was 5.0mmHg, area = 0.73. Preoperative patients with [P(v-a)CO2]m o r et h a n5 . 0 m m H g
presented a higher hospital mortality (36.4% versus 4.5%P = 0.004), higher prevalence of circulatory shock (56.8% versus
22.7%P = 0.01) and acute renal failure postoperatively (27.3% versus 4.5%P = 0.02), and longer hospital length of stays 20.0
(14.0–30.0) versus 13.5 (9.0–25.0) days P = 0.01. Conclusions.T h eP C O 2 gap values more than 5.0mmHg preoperatively were
associated with worse postoperatively outcome.
1.Introduction
Although every year millions of surgeries are performed all
around the world, few patients that undergo major surgeries
are judged to be of high risk for postoperative complications
and death [1]. An observational study reported that only
12.5% ofall surgical proceduresare considered high risk, but
over 80% of the deaths which occurred were in the high-
risk group [1]. Despite the high mortality rate, less than
15% of those patients are admitted to intensive care units
(ICU) [1], which shows that the individual risk may easily
be underestimated and that high-risk patients may not be
recognized.
Themechanisms bywhich inﬂammatory responseandtis-
sue hypoperfusion occur in major surgery are still not en-
tirely clear, but evidence indicates that oxygen requirements
increase signiﬁcantly as a result of the injury and metabolic
response to the trauma caused by the surgery. However, very
often high-risk patients are not able to increase their cardiac
outputand thusthe oxygendelivery[2].Therefore, those pa-
tients will more likely develop tissue hypoperfusion and
severe systemic inﬂammatory response and death due to the
organ dysfunction [3].
Surgical patients with a high risk for complications ad-
mitted to an ICU frequently die as a primary or secondary
consequence of hypoperfusion-related organ dysfunction or
severe infections [4, 5]. However, predictors of death caused
by tissue hypoperfusion are still not studied very much
in high-risk surgery patients. The [P(v-a)CO2] has been
reversely correlated to cardiac output in surgical patients [6–
8]. In a recent review, Lamia et al. [9] showed that PCO2
gap is a blood ﬂow marker to remove total CO2 produced by2 Anesthesiology Research and Practice
the peripheral tissue. Cuschieri et al. [10]h a v ef o u n dar e -
verse correlation between [P(cv-a)CO2] and cardiac index
with a central venous blood sample and suggested that, for
this purpose, a sample of central venous blood could be used
instead of blood from the pulmonary artery.
Intheliterature,weﬁndonlyveryfewprospectiveclinical
studies with surgical patients, which have evaluated the real
impact from[P(v-a)CO2] ascomplicationsand deathpreop-
erative marker in this population. Therefore, the objective of
this study was to evaluate the role of PCO2 gap as a predictor
for complications and death in high-risk surgical patients.
2.Methods
The study was performed in a tertiary hospital. It was ap-
proved by the local Ethics and Research Committees, and
a written postinformed consent was obtained from each
patient or legal responsible. The study design was a post hoc
analysis applying a cut point derived from the data, with
the following inclusion criteria: (1) patients aged 18 years
or older and (2) surgeries which required a central venous
catheter in intraoperative and intensive care in postoperative
phase.Patientswereselectedduringthepreanestheticevalua-
tion. High-risk surgeries were patients undergoing surgeries
with requested ICU postoperative stay and at least one of the
following:
(i) severe cardiorespiratory comorbidities (coronary in-
suﬃciency, chronic obstructive pulmonary disease,
previous stroke),
(ii) surgery scheduled for neoplasm resection (eso-
phagectomy, total gastrectomy) longer than 8 hours,
(iii) above 70 years-old, with evidenceof physiological re-
serve impairment involving at least one vital organ,
(iv) acute renal failure (blood urea nitrogen > 100mg/dL
or creatinine > 3mg/dL),
(v) advanced vascular disease, or aortal involvement,
(vi) massive acute intraoperative blood loss predicted,
(vii) severe nutritional disorders patients.
Patients undergoing palliative surgery, with low life ex-
pectancy, liver failure (Child B or C), patients with a func-
tional class IV heart failure or an echocardiogram-measured
ejection fraction of less than 30%, and those who did not
accept participating in the study were excluded. The patients
with a functional class IV heart failure or ejection fraction of
lessthan30%couldpresentﬂowalterationduetounderlying
disease, which is not related to surgery procedure.
At the time of the inclusion, the Multiple-Organ Dys-
function Syndrome(MODS)[11] and AcutePhysiology And
Chronic Health Evaluation (APACHE II) [12]s c o r e sw e r e
also evaluated by taking the worst values of their variables.
An echocardiogram, which isan integral part ofpreoperative
evaluation of high-risk surgical patients in our institution,
was performed to measure the ejection fraction and the
presence or absence of systolic or diastolic ventricular dys-
function, consideringthe increasingly clearliteraturedataon
their similarities regarding mortality and morbidity [13–16].
At the day of the surgery, patients were equipped with
central venous (positioned with the tip within the superior
vena cava) and arterial catheters. A chest X-ray conﬁrmed
central venous catheter position. Before anesthesia induc-
tion, in intraoperatively and postoperatively central ve-
nous and arterial blood samples were collected to measure
[P(v-a)CO2].
The surgical team decided on which therapy should be
used during the intraoperative period. In the postoperative
phase, the intensive care physician’s goal was to improve the
perfusion parameters according to standard in local institu-
tion; he had no knowledge about preoperative [P(v-a)CO2].
Theprimary endpointwashospitalmortality; allpatients
were therefore monitored until they were discharged from
hospital. The secondary endpoint was to check for the pres-
ence of an organ dysfunction, shock (need of vasoactive
drugs for over 1 hour, despite volemic resuscitation), acute
pulmonary dysfunction (PaO2/FiO2 ratio < 200), renal fail-
ure (increase of creatinine by 50% or urinary output of less
than 400mL in 24 hours), confusion (change in behavior,
memory lapses, or psychomotor agitation), and platelet
dysfunction (platelets reduced by 30% compared to the
basal value) in up to 24 hours in the postoperative period.
Diagnosis of postoperative infection was based on interna-
tionalconsensusguidelinesand/oruseofantibiotic[17].The
infections incidence during ICU length of stay and the time
of mechanical ventilation were veriﬁed, besides the hospital
length of stay.
Basedonthebest[P(v-a)CO2]valuewhich discriminated
hospital mortality, the patients were allocated in two groups:
narrow [P(v-a)CO2] (group 1) and wide [P(v-a)CO2]
(group 2).
2.1. Statistical Analysis. Initially, we described the demo-
graphic, clinical, and physiological characteristics from pa-
tients that were included in the study. Frequencies were cal-
culated to describe categorical variables. Quantitative vari-
ables were described by using measures of central tendency
and dispersion.
The statistical method to be used in the assessment of
each variable was chosen based on its distribution. Categori-
cal variables were analyzed through the Chi-square test, and
continuous variables through the mean with the Student’s t-
test for normal distribution and continuous variables with
irregular distribution were analyzed by means of the Mann-
Whitney Test. P values < 0.05 (two-tailed) were considered
signiﬁcant. ROC curves were used to test the discrimination
power of the groups in predicting clinical evolution (the
capacity of correctly classifying survivors and nonsurvivors)
and to determine the best cut-oﬀ value of tissue perfusion
in connection with hospital mortality. SPSS 13.0 was used to
analyze those calculations. Group 01patients were compared
to those of group 02. Box plots were created to compare
survivors and nonsurvivors in [P(v-a)CO2]i nd i ﬀerent time
points through Mann-Whitney test.
To determine the risk of hospital death we developed a
multivariable Cox proportional hazard model in the popu-
lation. Variables were included in the model if they reachedAnesthesiology Research and Practice 3
Table 1: Patient characteristics and comparison between patients with [P(v-a) CO2] < 5.0 and [P(v-a)CO2] ≥ 5.0.
Variables All patients
(n = 66)
[P(v-a)CO2] < 5.0mmHg
(n = 22)
[P(v-a)CO2] ≥ 5.0mmHg
(n = 44) P
Age 65.6 ±12.26 4 .6 ±13.56 6 .0 ±11.70 . 6 7
Males (%) 56.1 50.0 59.1 0.48
APACHE II 16.9 ±5.61 5 .8 ± 5.11 7 .4 ± 5.80 . 2 9
MODS 3 (1.0–4.0) 3.0 (1.0–4.0) 3.5 (1.0–4.5) 0.46
ASA (%) 0.65
I 6.6 9.5 5.0
II 68.9 71.4 67.5
III 24.6 19.0 27.5
Elective surgery (%) 95.5 95.5 95.5 1.00
Emergency surgery (%) 4.5 4.5 4.5 1.00
Gastrointestinal surgery (%) 78.8 81.8 73.3 0.38
[P (v-a) Co2] (mmHg) 5.4 ±2.03 .3 ±1.26 .5 ±1.40 . 0 0
Lactate (mmol/L) 1.5 ±0.81 .4 ± 0.61 .6 ± 0.90 . 3 5
Base excess (mmol/L) −0.7 (−3.0–0.6) −1.6 (−3.4–0.7) −0.5 (−2.4–0.6) 0.35
ScvO2 (%) 74.1 ±7.67 7 .0 ± 6.27 2 .7 ± 7.90 . 0 3
Ventricular dysfunction (%) 77.3 54.5 88.6 0.002
Ejection fraction (%) 63.7 ±9.56 3 .5 ±9.96 3 .9 ±92 0.93
Hemoglobin (g/dL) 11.4 ±1.71 1 .3 ±1.71 1 .5 ±1.70 . 7 0
Glucose (mg/dL) 120.0 ±54.2 120.7 ± 61.7 120.3 ± 50.80 . 9 8
ScvO2-central venous oxygen saturation; ASA: American Society of Anesthesiologists;values between bracketsrepresent the median and percentile 25–75%.
as i g n i ﬁ c a n c el e v e lo fP<0.05 in univariate analysis or were
clinically relevant. Mortality estimative curve was created
using the Cox method and compared by Cox regression.
3.Results
Over a period of 6 months, the study included66 patients, of
which 37 males and 29 females, with an average age of 65.6
years old. Elective surgeries were more frequent (Table 1).
During surgery, 50% of patients received blood trans-
fusions, 32.5% vasoactive drugs, and 54.5% of them had
complications, where circulatory shock was most prevalent
(Table 2).
A ROC curve was created in order to establish the best
[P(v-a)CO2] value, which discriminated hospital mortality
in this population, where [P(v-a)CO2] = 5.0mmHg was the
cut-oﬀ between narrow [P(v-a)CO2] and wide [P(v-a)CO2],
presentingsensitivityof93.3%andspeciﬁcityof50.2%,ROC
area of 0.73, P(area = 0.5) = 0.0006, 95% CI = 0.61 to 0.84
(Figure 1). Moreover, comparative ROC curves from lactate,
BE and ScvO2 can demonstrate that [P(v-a)CO2]h a dt h e
greatest AUC, respectively, 0.53 (0.41 to 0.67), 0.56 (0.43 to
0.69), and 0.71 (0.59 to 0.82).
A Box plot graphic has compared survivors and non
survivors in pre-, intra-, and postoperatively; it could show
that only the preoperatively period presented statistical
signiﬁcance between them (Figure 2).
Thus, when comparing the groups with narrow [P(v-
a)CO2] and wide [P(v-a)CO2], although they present the
same pre- and intraoperative demographic and clinical data,
exceptforalowerScvO 2 andahigherventriculardysfunction
in patients with [P(v-a)CO2] ≥ 5.0mmHg, we ﬁnd that
patients with [P(v-a)CO2] ≥ 5.0mmHg had a higher
hospital mortality and a higher incidence of complications
in the postoperative period, mainly circulatory shock, renal
failure, and ICU infection. (Tables 1, 2, 3,a n d4)
When patients with [P(v-a)CO2] < 5.0mmHg and
[P(v-a)CO2] ≥ 5.0mmHg were compared, the group with
[P(v-a)CO2] ≥ 5.0mmHg had a lower survival probability,
even when it was adjusted by MODS, ScvO2, ventricular
dysfunction heart. HR = 2.07 IC95% 1.14–3.77 (Figure 3).
4.Discussion
Despite the large quantity of resources that are directed to-
wardsassessing perioperativerisk andofcardiovascularcom-
plications, this study shows that a simple analysis of PCO2
gap ≥ 5.0mmHg in the preoperative period is an important
marker for postoperative complications, mainly shock, renal
failure, infection, increased length hospital stay, and hospital
mortality. Currently, few parameters are used at bed side
to assess tissue hypoxia, such as urinary output, base dif-
ferences, and blood lactate, but those parameters show that
hypoperfusion is already installed and may be late to guide
the onset of a hemodynamic resuscitation [18]. However, in
this study, [P(v-a)CO2] has proven to be an early parameter
to identify worse outcome in surgery patients.
The worse outcome of these patients can be explained
by previous reports that have suggested the PCO2 gap as a
marker for tissue hypoxia [19, 20]. In an animal model for4 Anesthesiology Research and Practice
Table 2: Patient characteristics and comparison between patients with [P(v-a)CO2] < 5.0 and [P(v-a)CO2] ≥ 5.0 in intraoperative.
Variables All patients
(n = 66)
[P(v-a)CO2] < 5.0mmHg
(n = 22)
[P(v-a)CO2] ≥ 5.0mmHg
(n = 44) P
Transfusion (%) 50.0 40.9 54.5 0.29
Crystalloids (mL) 7000 (4625–8875) 5500 (4500–8650) 7000 (5500–8875) 0.44
Colloids (mL) 1000 (500–1000) 500 (500–1250) 1000 (500–1000) 0.26
Fluid balance (ml) 800 (175–1420) 400 (−250–875) 800 (262–1750) 0.13
Vasopressors (%) 32.5 23.5 40.5 0.27
Length of surgery (hours) 6.9 ±2.47 .0 ± 3.16 .8 ± 1.90 . 8 3
Values between brackets represent the median and percentile 25–75%.
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Figure 1: Roc curve from [P(v-a)CO2] and hospital mortality.
acute hemorrhage, Van der Linden et al. [21]f o u n das i g -
niﬁcant correlation between blood lactate and PCO2 gap.
A progressive increase of [P(v-a)CO2] was observed during
the dependence period of oxygen consumption and delivery
(VO2/DO2) in another experimental model with progressive
ﬂow reduction [22]. High [P(v-a)CO2] values have been
reported during cardiac arrest and cardiopulmonary resus-
citation[19,23]. However,in all those studies, tissue hypoxia
was secondary to the reduction of blood ﬂow.
Circulatory failure is followed by tissue CO2 accumula-
tion. Tissue CO2 increases as a consequence of an accumula-
tion of the carbon dioxide produced by the aerobic metabo-
lism and by the tissue bicarbonate buﬀer eﬀect, which is
necessary to correct the excess of hydrogen ions during
the anaerobic metabolism. When the cell concentration of
bicarbonate ion (HCO3
−)a n dh y d r o g e ni o n( H +)r i s e s ,
HCO3
− diﬀuses out of red blood cells into the plasma, but
0
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Figure 2: Box plot between [P(v-a)CO2] value from survivors and
nonsurvivors (∗P<0.05; #P>0.05).
H+ cannot diﬀuse easily because the cell membrane is rel-
atively impermeable to cations. Some of H+ liberated are
bound to hemoglobin (Hb). This reaction occurs because
reduced Hb is a better acceptor of H+ than the oxygenated
Hb. In the peripheral blood the loading of CO2 is facilitated
by the presence of reduced Hb (Haldane eﬀect) [9].
Low blood ﬂow can result in tissue hypercapnia. Under
anaerobic metabolism conditions, it is expected that the
production of CO2 (VCO2) decreases less than the con-
sumption of O2 (VO2). In other words, the VCO2/VO2 ratio
(respiratory quotient) should increase. According to the Fick
equation, a low blood ﬂow may result in an increase of [P(v-
a)CO2], even without any additional production of CO2.
This can be explained by the CO2-stagnation phenomenon
[24] due to the slower microcirculation blood ﬂow, which is
larger than normal CO2 production; hypercapnia tends to be
generated in the venous circulation.
Therefore, [P(v-a)CO2]i sp r o p o r t i o n a lt oC O 2 produc-
tion and inversely related to cardiac output (Fick equation).
Anaerobic CO2 production occurs when tissue hypoxia is
present, mainly to protect bicarbonate ions against excess
protons, produced as a secondary consequence of adenosine
triphosphate hydrolysis [25].Anesthesiology Research and Practice 5
Table 3: Patient characteristics and comparisonbetween patients with adequate [P(v-a)CO2] < 5.0and [P(v-a)CO2] ≥ 5.0 in postoperative.
Variables All patients
(n = 66)
[P(v-a)CO2] < 5.0mmHg
(n = 22)
[P(v-a)CO2] ≥ 5.0mmHg
(n = 44) P
Transfusion (%) 18.2 18.2 18.2 1.00
Crystalloids (mL) 1900 (1000–2500) 1500 (1000–2875) 2000 (1000–2500) 0.77
Colloids (mL) 500 (500–875) 500 (500–750) 500 (500–1000) 1.00
Duration of mechanical ventilation (hours) 24 (12–24) 12 (12–24) 24 (12–30) 0.07
Values between brackets represent the median and percentile 25–75%.
Table 4: Outcomes.
Variables All patients
(n = 66)
[P(v-a)CO2] < 5.0mmHg
(n = 22)
[P(v-a)CO2] ≥ 5.0mmHg
(n = 44) RR P
Postoperative complications (%) 54.5 40.9 61.4 1.73 0.09
Shock 45.5 22.7 56.8 2.83 0.01
ARF 19.7 4.5 27.3 5.15 0.02
Platelet dysfunction 19.7 13.6 22.7 1.55 0.38
Infection 16.7 4.5 22.7 4.20 0.05
Acute pulmonary dysfunction 10.6 9.1 11.4 1.18 0.77
Confusional state 7.6 0.0 11.4 0.64 0.10
Length of ICU stay (days) 3.0 (2.0–4.0) 2.5 (1.0–4.0) 3.0 (2.0–4.5) 0.12
Hospital length of stay (days) 20.0 (12.5–27.5) 13.5 (9.0–25.0) 20.0 (14.0–30.0) 0.01
Hospital mortality (%) 25.8 4.5 36.4 2.10 0.004
ARF: acute renal failure; ICU: intensive care unit; values between brackets represent the median and percentile 25–75%; RR: relative risk.
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Figure 3: Kaplan Meier curve.
In this respect, an increased [P(v-a)CO2] value has been
reported in patients with low cardiac output and no global
tissue hypoxia, as demonstrated by the normal lactate levels
that were found [26]. This emphasizes the lack of speciﬁcity
of [P(v-a)CO2] in detecting tissue hypoxia. In this study,
we observed that even patients with inadequate [P(v-a)CO2]
values presented normal lactate or base diﬀerence values.
Serum lactate has been traditionally accepted like an indica-
tor of anaerobic metabolism and of tissue hypoxia, but it has
to be emphasized that, under normal conditions, the liver is
capableofincreasing themetabolismoftheproducedlactate;
this means that, in hypoxia and anaerobic metabolism
situations, a few hours may elapse between the onset of the
phenomenon and the detection of elevated lactate levels in
the blood [27], which explains why the lactate may not be as
early as of the [P(v-a)CO2].
Otherwise, a normal [P(v-a)CO2] value may be associ-
ated with global tissue hypoxia in normal or hyperdynamic
states, which was demonstrated by some authors [28]. This
fact explains why an elevatedvenousﬂow issuﬃcienttoclear
the CO2 that is produced by the hypoxic cell, even if the
production of CO2 is higher than normal due to the anaero-
biosis that generates CO2 [24]. Indeed, Vallet and colleagues
evidenced that PCO2 gap increased during low blood ﬂow-
induced tissue hypoxia (ischemic hypoxia) while it remained
unchanged during hypoxemia-induced hypoxia (hypoxic
hypoxia) [29]. We emphasize once again the poor sensitivity
of [P(v-a)CO2] to detect tissue hypoxia in some cases. How-
ever, in this study, patients with an inadequate [P(v-a)CO2]
had a lower ScvO2,w h i c hm a yb ee x p l a i n e db yt h ef a c t
that ScvO2 is inﬂuenced by diﬀerent variables [30], such as
low blood ﬂow; this might be occurring with the sample in
q u e s t i o n .T h i sh y p o t h e s i si ss u b s t a n t i a t e db yah i g h e rp e r -
centage of ventricular dysfunction in this group.6 Anesthesiology Research and Practice
The prevalence of ventricular dysfunction in this study
was evaluated, considering both the systolic and diastolic
ventricular dysfunction, since their evolution as for mor-
bidity and mortality is similar [13–16]. A greater preva-
lence of ventricular dysfunction was found in the inadequate
[P(v-a)CO2] group. The EF—close to 65% in both groups—
reﬂects a predominant diastolic dysfunction, which substan-
tiates current data, which present diastolic dysfunction as a
more relevant prognosis predictor than EF per se. [31–34].
However, Vall´ ee et al. [35]f o u n dt h a taS c v O 2 of over
70% in septic patients was not enough to reach adequate
resuscitation, and that [P(v-a)CO2] ≥6.0mmHg could be
h e l p f u lt oi d e n t i f yp a t i e n t st hat were not adequately resus-
citated. Mekontso-Dessap et al. [24]d e m o n s t r a t e dt h a t ,
under conditions of tissue hypoperfusion, deﬁned as a blood
lactate level of >2.0mmol/L, a PvCO2-PaCO2/Ca-vO2 ratio
of >1.4 was the best predictor of hyperlactatemia and a good
prognostic index.
Thus, it is important to detect early a risk factor for low
oxygendeliveryduetolowbloodﬂowevaluatedbyPCO2 gap
≥5.0mmHg in surgery patients, because changes in clinical
management may be made in order to avoid an unfavorable
outcome in this population. Several clinical studies have
documented that and aggressive early resuscitation using
deﬁned protocols improve the patient’s outcome [36, 37].
These studies used therapy strategies to increase the cardiac
function and keep organ perfusion, which reduced the ICU
length of stay, accelerated the recovery of the gastrointestinal
function, and reduced the mortality rate in high-risk surgery
patients [38]. Therefore, [P(v-a)CO2] could help identify
patients that require such optimizations in the preoperative
phase and speciﬁc measures taken in the preoperative or
intraoperative period to ensure that the increase of blood
ﬂow could bring beneﬁts to the postoperative period and
improve the prognosis.
However, in this study, the [P(v-a)CO2] value that best
discriminated mortality was lower than of those described
previously in the literature. This can be probably explained
by the fact that those studies discussed more severe patients
with septic conditions that required high oxygen delivery,
contrary to what was shown in the study in question, since
their patients were in the preoperative period of elective
surgeries, with low APACHE II values, most of them in ASA
II physical condition. In addition, values of the inadequate
[P(v-a)CO2] found in this evaluation may eventually mean
that the patients were not well enough to undergo major
surgeries, but tolerable for basal activities, which are not
comparable to the stress experienced in a surgical procedure.
Another aspect that has to be discussed is related to the
fact that inadequate [P(v-a)CO2] was found only in the pre-
operative and not in the intraoperative phase; it is impor-
tant to highlight that in the intraoperative period some
variables may interfere in the measurement of [P(v-a)CO2],
such as the anesthesia and hypothermia that might occur
during surgery; they may reduce cell respiration and, thus,
CO2production. Hypothermia reduces metabolism by 7%
per grade, with reduction of ATP formation and reduction
ofcellularoxygenandcerebralglucoserequirements,inaddi-
tion, decrease in CO2 production and O2 consumption [39].
Otheraspectscanbringimpacttochangein[P(v-a)CO2],
due to CO2 dissociation curve, which is curvilinear more
than oxygen dissociation curve, and temperature, hemat-
ocrit, oxygen saturation, and pH inﬂuence the PCO2/CO2
content relationship an example is showed when metabolic
acidosis worsens; the relationship is shifted to the right; it
means that the same CO2 content value can determinate su-
perior PCO2 value [9].
Besides, although in most studies that evaluated [P(v-
a)CO2] patients were monitored by means of a pulmonary
artery catheter [24], absence of this tool in this study does
not limit the results that were found. By the other hand, the
gastric tonometry has also been utilized as carbon dioxide
monitoring [40], but this method assesses the regional tissue
dysoxia, diﬀerently of the proposal from present study which
has aimed to measure the systemically problem. Therefore,
since the study’s objective does not require the measures that
are evaluated by these devices, this way can be cheaper.
The complications,exceptinfection, were evaluatedin24
hours only, which makes a limitation, but the length of ICU
stay of all patients was short, that is, median 3.0 days.
The sample sizes as well as the observational character of
this study are limiting factors. Future researches are needed
to validate this ﬁnding.
Therefore, patients who underwent major surgeries and
that—in the preoperative period—presented a PCO2 gap
≥5mmHg had a worse prognosis in the postoperative. This
marker may turnouttobeimportant tostratify risk and sug-
gests a useful additional tool for perioperative management.
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